<DOC>
	<DOCNO>NCT00398216</DOCNO>
	<brief_summary>This study ass DU176b effective prevention blood clot follow hip replacement surgery . The duration 7-10 day treatment 30 60 day follow-up visit .</brief_summary>
	<brief_title>A Study DU-176b Preventing Blood Clots After Hip Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<mesh_term>Factor Xa Inhibitors</mesh_term>
	<criteria>1 . 18 year age old ; male female . 2 . Able provide write informed consent . 3 . Must schedule elective unilateral total hip replacement surgery . Only primary surgery accept . 4 . If female , must either one year postmenopausal , surgically sterile , use medically accept contraceptive measure judge Investigator accordance local regulatory requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Anti-coagulant</keyword>
	<keyword>hip replacement</keyword>
	<keyword>hip replacement surgery</keyword>
	<keyword>unilateral hip replacement surgery</keyword>
	<keyword>DeepVein Thrombosis</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>pulmonary embolism</keyword>
	<keyword>Prevention Blood Clots</keyword>
</DOC>